A Response to: Letter to the Editor Regarding “Tafamidis 61 mg Patient Characteristics and Persistency? A Retrospective Analysis of German Statutory Health Insurance Data (IQVIA™ LRx)”
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-10-01
|
| Series: | Cardiology and Therapy |
| Online Access: | https://doi.org/10.1007/s40119-024-00383-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|